Lexicon Pharmaceuticals Inc
LXRX
Market Cap$665.15M
Close$
$-0.39
122.1% downside
Current Fair Value
122.1% downsideOvervalued by 122.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $665.15 Million |
|---|---|
| Enterprise Value | $409.42 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.82 |
| Beta | 1.32 |
| Outstanding Shares | 361,492,295 |
| Avg 30 Day Volume | 2,816,347 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.44 |
|---|---|
| PEG | -6.66 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 177.24 |
| Enterprise Value to EBIT | -2.2 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 0.35 |
Revenue Sources
No data
ESG Score
No data